Biohaven Ltd. (BHVN)

Biohaven Statistics

Total Valuation

Biohaven has a market cap or net worth of $1.52 billion. The enterprise value is $1.15 billion.

Market Cap	1.52B
Enterprise Value	1.15B

Important Dates

The last earnings date was Monday, August 11, 2025, before market open.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Biohaven has 105.79 million shares outstanding. The number of shares has increased by 26.59% in one year.

Current Share Class	105.79M
Shares Outstanding	105.79M
Shares Change (YoY)	+26.59%
Shares Change (QoQ)	+0.42%
Owned by Insiders (%)	11.14%
Owned by Institutions (%)	80.85%
Float	88.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	38.28
PB Ratio	11.31
P/TBV Ratio	13.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.82, with a Debt / Equity ratio of 0.26.

Current Ratio	3.82
Quick Ratio	3.26
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -295.94% and return on invested capital (ROIC) is -169.61%.

Return on Equity (ROE)	-295.94%
Return on Assets (ROA)	-87.20%
Return on Invested Capital (ROIC)	-169.61%
Return on Capital Employed (ROCE)	-185.51%
Revenue Per Employee	n/a
Profits Per Employee	-$3.00M
Employee Count	256
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Biohaven has paid $859,000 in taxes.

Income Tax	859,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.08% in the last 52 weeks. The beta is 3.50, so Biohaven's price volatility has been higher than the market average.

Beta (5Y)	3.50
52-Week Price Change	-61.08%
50-Day Moving Average	14.62
200-Day Moving Average	28.89
Relative Strength Index (RSI)	49.82
Average Volume (20 Days)	2,101,324

Short Selling Information

The latest short interest is 12.71 million, so 12.02% of the outstanding shares have been sold short.

Short Interest	12.71M
Short Previous Month	12.24M
Short % of Shares Out	12.02%
Short % of Float	14.39%
Short Ratio (days to cover)	6.72

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-790.46M
Pretax Income	-750.36M
Net Income	-766.97M
EBITDA	-781.78M
EBIT	-790.46M
Earnings Per Share (EPS)	-$7.65

Balance Sheet

The company has $404.98 million in cash and $34.49 million in debt, giving a net cash position of $370.49 million or $3.50 per share.

Cash & Cash Equivalents	404.98M
Total Debt	34.49M
Net Cash	370.49M
Net Cash Per Share	$3.50
Equity (Book Value)	134.59M
Book Value Per Share	1.27
Working Capital	350.50M

Cash Flow

In the last 12 months, operating cash flow was -$645.08 million and capital expenditures -$1.35 million, giving a free cash flow of -$646.43 million.

Operating Cash Flow	-645.08M
Capital Expenditures	-1.35M
Free Cash Flow	-646.43M
FCF Per Share	-$6.11

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biohaven does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.59%
Shareholder Yield	-26.59%
Earnings Yield	-50.38%
FCF Yield	-42.46%

Analyst Forecast

The average price target for Biohaven is $54.17, which is 276.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$54.17
Price Target Difference	276.44%
Analyst Consensus	Strong Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-23.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2